MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0200938
Bioaltus Laboratories Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.03 Cr
▲ 54% YoY
Net profit · FY 2025
₹43.62 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹69.33 Lakh
EBITDA margin 3.6%
Authorised capital
₹2.1 Cr
Registered with MCA
Paid-up capital
₹2.02 Cr
Issued & subscribed
Open charges
₹16.5 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Bioaltus Laboratories Private Limited
Data last updated:
Bioaltus Laboratories Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2015PTC264964. Its GSTIN is 27AAGCB3020L1ZU (Maharashtra).
The company has an authorised share capital of ₹2.1 Cr and a paid-up capital of ₹2.02 Cr. It is led by directors Sanket Suresh Patil (Managing Director) and Siya Sanket Patil.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 16 1st Floor Tropical Lagoon, Tl 5 Kavesar G.B. Road Thane West, Maharashtra, India – 400615.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.03 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹43.62 Lakh (net margin 2.3%) and EBITDA of ₹69.33 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 78% over three years and 82% over five years.
The company is associated with 2 brands: Bioaltuslabs and Bioaltus. As per MCA filings, the company has open charges of ₹16.5 Cr on record.
Bioaltus Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0200938). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioaltus.com.
Company Details of Bioaltus Laboratories Private Limited
CIN U74900MH2015PTC264964
Registration Number 264964
Incorporation Date 28 May 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0200938
Recognitions & Rankings of Bioaltus Laboratories
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. 16 1st Floor Tropical Lagoon, Tl 5 Kavesar G.B. Road Thane West, Maharashtra, India – 400615
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Bioaltus Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Bioaltus Laboratories Private Limited
Bioaltus Laboratories operates two associated brands: Bioaltuslabs and Bioaltus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| bioaltuslabs.com | ||
| Provides contract manufacturing and pharmaceutical products for medical fields like diabetology and cardiology. | bioaltus.com |
Business Activity of Bioaltus Laboratories Private Limited
The main business activity of Bioaltus Laboratories is professional, scientific and technical. In detail, this covers veterinary activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M8 | Veterinary activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bioaltus Laboratories Private Limited FY 2024 filings available
Bioaltus Laboratories Private Limited reported revenue of ₹19.03 Cr (up 54% YoY) for FY 2025.
Revenue · FY 2025
₹19.03 Cr ▲ 54%
Net profit · FY 2025
₹43.62 Lakh margin 2.3%
EBITDA · FY 2025
₹69.33 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR) of Bioaltus Laboratories Private Limited
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 78%
5 years · compounded
▲ 82%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 73%
5 years · compounded
▲ 55%
Revenue has grown at a compounded annual rate (CAGR) of 82% over five years, including 54% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bioaltus Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹69.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹43.62 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bioaltus Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bioaltus Laboratories are in the company report.
Premium access
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bioaltus Laboratories Private Limited
Bioaltus Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siya Sanket Patil | Additional Director | 07 Mar 2023 | 3 Years 7 Months | Current |
| Sanket Suresh Patil | Managing Director | 28 May 2015 | 11 Years 4 Months | Current |
Peer Comparison of Bioaltus Laboratories Private Limited
Bioaltus Laboratories Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Turtle Shell Technologies Private Limited | ₹19.09 Cr (FY 2025) | •••• | •••• | 192.0% | •••• | Bengaluru, Karnataka, India |
| Srinija Drugs Private Limited | ₹19.09 Cr (FY 2024) | •••• | •••• | 64.0% | •••• | Andhra Pradesh, India |
| Omega Biotech Limited | ₹19.07 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Maha Avtar Health Care Private Limited | ₹19.06 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Delhi, India |
| Harmony Lifescience Private Limited | ₹19.06 Cr (FY 2022) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Bioaltus Laboratories Private Limited this company | ₹19.03 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Thane, Maharashtra, India |
| Lifax Pharma Private Limited | ₹19.03 Cr (FY 2024) | •••• | •••• | 324.0% | •••• | Kollam, Kerala, India |
| I G Pharma Limited | ₹18.98 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Roorkee, Uttarakhand, India |
| Vanguard Therapeutics Private Limited | ₹18.98 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Telangana, India |
| Tablets Medopharm Private Limited | ₹18.97 Cr (FY 2025) | •••• | •••• | 63.0% | •••• | Chennai, Tamil Nadu, India |
| TVB Healthcare Private Limited | ₹18.97 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Bioaltus Laboratories by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bioaltus Laboratories Private Limited
Bioaltus Laboratories Private Limited is audited by A T M S & Co LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A T M S & Co LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Bioaltus Laboratories Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bioaltus Laboratories Private Limited
Open charges
₹16.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 2024 | State Bank of India | ₹16.5 Cr | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Bioaltus Laboratories Private Limited
Bioaltus Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 29 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Delta Finochem Private Limited | •••• | •••• | •••• |
| Precise Biopharma Private Limited | •••• | •••• | •••• |
| Excel Industries Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Laxachem Organics Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Bioaltus Laboratories Private Limited
Employment history and EPFO contributions of people linked to Bioaltus Laboratories.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bioaltus Laboratories Private Limited
Bioaltus Laboratories Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Sanket Suresh Patil ceased to be Director on 30 Mar 2023.
AGM
Bioaltus Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 16.50 Cr with Charge ID 100927652 was registered on 07 May 2024.
Filing
Bioaltus Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Sanket Suresh Patil ceased to be Director.
Ceased
Ankit Varshney ceased to be Director.
Ceased
Gopinath Ramankutty Nair ceased to be Director.
Appointed
Siya Sanket Patil was appointed as Additional Director.
Appointed
Sanket Suresh Patil was appointed as Managing Director.
Incorporation
28 May 2015
Bioaltus Laboratories Private Limited was registered on 28 May 2015 with Roc Mumbai & aged 11 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Bioaltus Laboratories Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bioaltus Laboratories Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bioaltus Laboratories Private Limited
Bioaltus Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCB3020L1ZU | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bioaltus Laboratories Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioaltus Laboratories Private Limited
Bioaltus Laboratories is an active private limited company based in Thane, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 May 2015 (11+ years old) and is registered under CIN U74900MH2015PTC264964.
Bioaltus Laboratories reported revenue of ₹19.03 Cr for FY 2025 (up 54% YoY).
Bioaltus Laboratories has 2 current directors:
- Sanket Suresh Patil - Managing Director
- Siya Sanket Patil - Additional Director
Bioaltus Laboratories reported a net profit of ₹43.62 Lakh (net margin 2.3%) and EBITDA of ₹69.33 Lakh (EBITDA margin 3.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bioaltus Laboratories is 78% over three years and 82% over five years. In the latest year (FY 2025) revenue rose 54%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bioaltus Laboratories is 27AAGCB3020L1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bioaltus Laboratories is U74900MH2015PTC264964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioaltus Laboratories was incorporated on 28 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bioaltus Laboratories by revenue are Turtle Shell Technologies Private Limited, Srinija Drugs Private Limited, Omega Biotech Limited, Maha Avtar Health Care Private Limited, Harmony Lifescience Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Sanket Suresh Patil ceased to be Director on 30 Mar 2023. Ankit Varshney ceased to be Director on 07 Mar 2023. Gopinath Ramankutty Nair ceased to be Director on 07 Mar 2023. Bioaltus Laboratories has 5 board changes on record in total.
Yes, Bioaltus Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0200938).
Bioaltus Laboratories has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 29 overdue payments to 7 micro and small suppliers. The latest return was filed on 29 Oct 2023.